Profund Advisors LLC Sells 3,592 Shares of Stryker Co. (SYK)
Profund Advisors LLC decreased its stake in Stryker Co. (NYSE:SYK) by 23.5% during the 4th quarter, Holdings Channel reports. The firm owned 11,671 shares of the medical technology company’s stock after selling 3,592 shares during the period. Profund Advisors LLC’s holdings in Stryker were worth $1,807,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Truewealth LLC bought a new stake in shares of Stryker in the 4th quarter worth approximately $110,000. Sawyer & Company Inc bought a new stake in shares of Stryker in the 4th quarter worth approximately $125,000. Sit Investment Associates Inc. lifted its holdings in shares of Stryker by 114.3% in the 4th quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock worth $128,000 after purchasing an additional 440 shares during the last quarter. San Francisco Sentry Investment Group CA lifted its holdings in shares of Stryker by 47.8% in the 3rd quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock worth $143,000 after purchasing an additional 325 shares during the last quarter. Finally, Oak Point Wealth Management bought a new stake in shares of Stryker in the 4th quarter worth approximately $145,000. 74.99% of the stock is currently owned by institutional investors and hedge funds.
Shares of Stryker Co. (SYK) opened at $166.41 on Friday. Stryker Co. has a 12 month low of $129.29 and a 12 month high of $170.00. The company has a quick ratio of 1.59, a current ratio of 2.29 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $62,344.18, a price-to-earnings ratio of 25.64, a PEG ratio of 2.39 and a beta of 0.70.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be paid a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date is Wednesday, March 28th. Stryker’s dividend payout ratio is presently 70.15%.
SYK has been the topic of several recent research reports. Royal Bank of Canada reissued a “buy” rating and issued a $175.00 price target on shares of Stryker in a report on Tuesday, January 9th. ValuEngine raised Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, November 14th. SunTrust Banks reaffirmed a “buy” rating and set a $161.00 target price on shares of Stryker in a research note on Friday, November 17th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $170.00 target price on shares of Stryker in a research note on Wednesday, January 31st. Finally, Guggenheim reaffirmed a “buy” rating on shares of Stryker in a research note on Wednesday, January 31st. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. Stryker presently has an average rating of “Buy” and a consensus price target of $163.85.
In other news, Director Howard E. Cox, Jr. sold 7,400 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $164.09, for a total value of $1,214,266.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Katherine Ann Owen sold 3,700 shares of the business’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $161.66, for a total value of $598,142.00. Following the completion of the sale, the vice president now directly owns 7,596 shares in the company, valued at approximately $1,227,969.36. The disclosure for this sale can be found here. Insiders sold a total of 20,390 shares of company stock worth $3,324,962 in the last three months. Company insiders own 7.40% of the company’s stock.
WARNING: This piece was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/03/11/profund-advisors-llc-sells-3592-shares-of-stryker-co-syk.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.